Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Bre

Project: Research project

Description

Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk
StatusFinished
Effective start/end date1/1/155/31/17

Funding

  • University of Alabama at Birmingham

Fingerprint

Tamoxifen
Hodgkin Disease
Breast Neoplasms